Brief: Gritstone Bio Reports Fourth Quarter And Full Year 2022 Financial Results
March 9 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
* GRITSTONE BIO INC - CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES, AND RESTRICTED CASH OF $185.2 MILLION AS OF DECEMBER
31, 2022
Source text for Eikon: ID:nGNX1DNX4V
Further company coverage: GRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy